van der Schaar Lab: What gets hidden when medicine is built around the average patient?
MihaelaVDS · x · 2026-08-27
The van der Schaar Lab published a new blog reviewing their work on cardiovascular disease, breast cancer, and clinical pathways. The core argument is that building medicine around the "average patient" obscures individual differences and risks. The article explores how machine learning can uncover these overlooked risks, personalize decisions, and increase the transparency of clinical pathways. The goal is not just higher average accuracy, but discovering who is being overlooked and why.
Related event: Cambridge Lab: Medicine Built on the 'Average Patient' Fails Women(2 posts)→
More from Research
- New Preprint Explores AI Academic Research — bgoncalves · 2026-08-27
- PULSE AI reconstructs molecular profiles from routine clinical data — bravo_abad · 2026-08-27
- X-Square's WALL-SS World Model Enables Reliable Transfer from Virtual to Physical Robot Tasks — APPSO · 2026-08-27
- Open-source bipedal robot Microduck supports RL training for under $400 — Thom_Wolf · 2026-08-27
- AI Cancer Vaccine Succeeds in Phase 3, Pricing Projected at $475k — 量子位 · 2026-08-27
- Zero-Shot Generalist Agents Beat Trained Models in Vision-Language Navigation Without Scaffolding — 机器之心 · 2026-08-27